反応式
[NH2:1][C:2]1[N:7]=[C:6]2[N:8]([CH2:11][C:12]([OH:14])=O)[N:9]=[CH:10][C:5]2=[C:4]([C:15]2[O:16][CH:17]=[CH:18][CH:19]=2)[N:3]=1.[C:20]([C:27]1[NH:28][CH:29]=[CH:30][N:31]=1)([C:22]1NC=CN=1)=O.NC1C=CC=CN=1>CN(C=O)C.O>[NH2:1][C:2]1[N:7]=[C:6]2[N:8]([CH2:11][C:12]([NH:28][C:27]3[CH:20]=[CH:22][CH:29]=[CH:30][N:31]=3)=[O:14])[N:9]=[CH:10][C:5]2=[C:4]([C:15]2[O:16][CH:17]=[CH:18][CH:19]=2)[N:3]=1参加物
6
反応物 3
生成物 1
試薬・触媒・溶媒 2
実験手順
A solution of 6-amino-4-(2-furyl)-1H-pyrazolo[3,4-d]pyrimidin-1-ylacetic acid (200 mg, 0.77 mmol) in DMF (3 mL) was treated with carbonyl diimidazole (125 mg, 0.77 mmol), stirred at room temperature for 2 h, treated with 2-aminopyridine (72 mg, 0.77 mmol), heated to 50° C. for 3 h, cooled and diluted with water. The resulting white solid was filtered, suspended in MeOH, treated with HCl in dioxan (4-M, 1 mL) diluted with diethyl ether and filtered to give the title compound (187 mg, 59%) as a yellow solid.
後処理
- temperatureheated to 50° C. for 3 h
- temperaturecooled
- filtrationThe resulting white solid was filtered
- additiontreated with HCl in dioxan (4-M, 1 mL)
- additiondiluted with diethyl ether
- filtrationfiltered
出典と根拠
- ORDレコード
- ord-28f3659d05ae473f85bdaab236f584c2
- 出典データセット
- uspto-grants-2009_12
- 特許番号
- US07629349B2
関連ノート
読み込み中…